Compare metabolites in 2 of these studies:
Study A:   Study B:  

List of Studies ( Metabolite:Hepoxilin B3)

Study_idAnalysis_idStudy_titleSourceSpeciesDiseaseInstituteUnits(range)
ST001856 AN003009 The metabolomic resetting effect of FG4592 in AKI to CKD transition-day 21 (Part 2) Kidney Mouse Kidney disease Children's Hospital of Nanjing Medical University AUC
ST000916 AN001491 Biomarkers of NAFLD progression: a lipidomics approach to an epidemic. Part 2:Plasma Blood Human Fatty liver disease LIPID MAPS nM
ST003049 AN005000 Plasma instead of serum avoids critical confounding of clinical metabolomics studies by platelets Blood Human University of Vienna normalized AUC
ST000915 AN001485 Biomarkers of NAFLD progression: a lipidomics approach to an epidemic. Part 2:Liver Liver Human Fatty liver disease LIPID MAPS pmol/mg
  logo